Electrovaya (EFL) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue reached $11.2 million with over 30% gross margin and positive adjusted EBITDA for the seventh consecutive quarter.

• Balance sheet strengthened by $12.8 million equity raise and debt repayment, supporting US manufacturing expansion.

• Secured a $51 million EXIM Bank direct loan approval to expand lithium-ion cell manufacturing in Jamestown, NY.

• Commercial operations in Jamestown expected to commence in April 2025, with accelerated assembly plans and hiring underway.

• FY2025 revenue guidance reaffirmed to exceed $60 million, driven by strong order pipeline and customer demand.

Financial highlights

• Q1 2025 revenue was $11.2 million, down from $12.1 million in Q1 2024 due to delivery timing.

• Gross margin improved to 30.5% from 29.2% in the prior quarter; battery system margin was 30.8%.

• Adjusted EBITDA was $0.6 million, flat year-over-year, marking seven consecutive positive quarters.

• Net loss for the quarter was $0.4 million, impacted by higher finance costs and non-recurring operating expenses.

• Net working capital improved to $12.6 million, with cash in hand at $8.2 million, and total debt at $15.3 million.

Outlook and guidance

• FY2025 revenue expected to exceed $60 million, with ramp-up beginning in Q2 and sequential growth anticipated.

• Guidance incorporates potential revenue deferrals to FY2026 and is subject to order timing.

• Jamestown facility assembly operations to start in April 2025; cell production to begin mid-2026.